Inventiva (IVA) Total Debt (2018 - 2025)
Inventiva (IVA) recorded quarterly Total Debt of $58.5 billion in Q2 2025, up 12.79% quarter-over-quarter from $51.8 billion in Q4 2024, and up 60655.31% on a YoY basis from N/an in Q2 2024.
Inventiva (IVA) Total Debt (2018 - 2025) Analysis & Trends
Inventiva's Total Debt history runs 8 years deep, the most recent figure standing at $58.5 billion for Q2 2025.
- In Q2 2025, Total Debt rose 60655.31% year-over-year to $58.5 billion; the TTM figure through Jun 2025 stood at $58.5 billion (up 60655.31% YoY), while the FY2024 annual figure was $51.8 billion, up 176971.58% from the prior year.
- Total Debt was $58.5 billion for Q2 2025 at Inventiva, up from $51.8 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $58.5 billion in Q2 2025 to a low of $11.6 million in Q4 2021.
- Historically, Total Debt has averaged $12.5 billion across 5 years, with a median of $62.0 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Total Debt tumbled 99.55% in 2023, then soared 176971.58% in 2024.
- A 5-year view of Total Debt shows it stood at $11.6 million in 2021, then surged by 414.29% to $59.5 million in 2022, then slumped by 50.83% to $29.3 million in 2023, then jumped by 176971.58% to $51.8 billion in 2024, then increased by 12.79% to $58.5 billion in 2025.
- The last three Total Debt figures came in at $58.5 billion (Q2 2025), $51.8 billion (Q4 2024), and $96.2 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 58.46 Bn |
| Dec 31, 2024 | 51.83 Bn |
| Jun 30, 2024 | 96.23 Mn |
| Dec 31, 2023 | 29.27 Mn |
| Jun 30, 2023 | 64.53 Mn |
| Dec 31, 2022 | 59.53 Mn |
| Jun 30, 2022 | 14.34 Bn |
| Dec 31, 2021 | 11.58 Mn |
| Jun 30, 2021 | 12.14 Mn |
| Mar 31, 2021 | 12.15 Mn |
| Dec 31, 2020 | 11.99 Mn |
| Dec 31, 2019 | 127,292.08 |
| Dec 31, 2018 | 256,814.20 |